drugset / Trial / NCT01367912

Timing of Estrogen Support During the Luteal Phase of in Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycle

NCT01367912

RandomizedParallel-groupSingle-blindTreatment

Summary

To test the hypothesis that adding estradiol (E2) to progesterone supplementation later in the luteal phase of in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles, rather than earlier in the luteal phase, improves clinical pregnancy rates (PRs).

Timeline

Start
2008-02
Primary completion
2008-11
Completion
2008-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 2 mg Oral

Indications